Jeremiah J Morrissey1, Jonathan Mobley2, Joseph Song2, Joel Vetter2, Jingqin Luo3, Sam Bhayani2, R Sherburne Figenshau2, Evan D Kharasch4. 1. Division of Clinical and Translational Research, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO. Electronic address: morrisse@wustl.edu. 2. Division of Urology, Washington University School of Medicine, St. Louis, MO. 3. Division of Biostatistics, Washington University School of Medicine, St. Louis, MO. 4. Division of Clinical and Translational Research, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO.
Abstract
OBJECTIVE: To evaluate the trends in urine aquaporin-1 (AQP1) and perilipin 2 (PLIN2) concentrations in patients with clear cell and papillary renal cell carcinoma (RCC), we determined the relationship between the urine concentration of these biomarkers and tumor size, grade, and stage. MATERIALS AND METHODS: The biomarker concentrations were determined by sensitive and specific Western blot procedures normalized to the urine creatinine excretion. The analysis included 61 patients undergoing partial or radical nephrectomy for clear cell or papillary RCC and 43 age- and sex-matched control patients. Relationships between urine biomarker concentrations and tumor size, stage, and grade were assessed. RESULTS: Patients with RCC had 35-fold and 9-fold higher median urinary AQP1 and PLIN2 concentrations, respectively, compared with controls. Both tumor markers decreased after tumor resection to concentrations equivalent to those of controls. The sensitivity and specificity were both 100% for AQP1 and 92% and 100%, respectively, for PLIN2. A significant linear correlation was found between the tumor size and the prenephrectomy AQP1 (Spearman coefficient 0.78, P <.001) and PLIN2 (Spearman coefficient 0.69, P <.001) concentrations. A correlation was found for both markers with tumor stage (overall P = .030), when the stage was dependent primarily on the tumor size (stages T1 and T2), but not with stage T3, which reflected extrarenal spread. Neither marker showed a significant correlation with tumor grade. CONCLUSION: AQP1 and PLIN2 were significantly increased in patients with clear cell and papillary RCC compared with controls. The preoperative urinary concentrations of these markers reflected the tumor size and stage.
OBJECTIVE: To evaluate the trends in urine aquaporin-1 (AQP1) and perilipin 2 (PLIN2) concentrations in patients with clear cell and papillary renal cell carcinoma (RCC), we determined the relationship between the urine concentration of these biomarkers and tumor size, grade, and stage. MATERIALS AND METHODS: The biomarker concentrations were determined by sensitive and specific Western blot procedures normalized to the urine creatinine excretion. The analysis included 61 patients undergoing partial or radical nephrectomy for clear cell or papillary RCC and 43 age- and sex-matched control patients. Relationships between urine biomarker concentrations and tumor size, stage, and grade were assessed. RESULTS:Patients with RCC had 35-fold and 9-fold higher median urinary AQP1 and PLIN2 concentrations, respectively, compared with controls. Both tumor markers decreased after tumor resection to concentrations equivalent to those of controls. The sensitivity and specificity were both 100% for AQP1 and 92% and 100%, respectively, for PLIN2. A significant linear correlation was found between the tumor size and the prenephrectomy AQP1 (Spearman coefficient 0.78, P <.001) and PLIN2 (Spearman coefficient 0.69, P <.001) concentrations. A correlation was found for both markers with tumor stage (overall P = .030), when the stage was dependent primarily on the tumor size (stages T1 and T2), but not with stage T3, which reflected extrarenal spread. Neither marker showed a significant correlation with tumor grade. CONCLUSION:AQP1 and PLIN2 were significantly increased in patients with clear cell and papillary RCC compared with controls. The preoperative urinary concentrations of these markers reflected the tumor size and stage.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow Journal: Am J Epidemiol Date: 2008-06-09 Impact factor: 4.897
Authors: Mark A Rogers; Paul Clarke; Jason Noble; Nicholas P Munro; Alan Paul; Peter J Selby; Rosamonde E Banks Journal: Cancer Res Date: 2003-10-15 Impact factor: 12.701
Authors: Jeremiah J Morrissey; Vincent M Mellnick; Jingqin Luo; Marilyn J Siegel; R Sherburne Figenshau; Sam Bhayani; Evan D Kharasch Journal: JAMA Oncol Date: 2015-05 Impact factor: 31.777
Authors: Joseph B Song; Jeremiah J Morrissey; Jonathan M Mobley; Karen G Figenshau; Joel M Vetter; Sam B Bhayani; Evan D Kharasch; Robert Sherburne Figenshau Journal: Int J Urol Date: 2018-11-22 Impact factor: 3.369
Authors: Jeremiah J Morrissey; Jonathan Mobley; R Sherburne Figenshau; Joel Vetter; Sam Bhayani; Evan D Kharasch Journal: Mayo Clin Proc Date: 2015-01 Impact factor: 7.616
Authors: Marina O Golovastova; Larisa V Tsoy; Anna V Bocharnikova; Dmitry O Korolev; Olga S Gancharova; Ekaterina A Alekseeva; Ekaterina B Kuznetsova; Lyudmila V Savvateeva; Elena E Skorikova; Vladimir V Strelnikov; Vladimir A Varshavsky; Andrey Z Vinarov; Vladimir N Nikolenko; Peter V Glybochko; Evgeni Yu Zernii; Andrey A Zamyatnin; Alexandr V Bazhin; Pavel P Philippov Journal: Tumour Biol Date: 2016-01-26
Authors: A L Pastore; G Palleschi; L Silvestri; D Moschese; S Ricci; V Petrozza; A Carbone; A Di Carlo Journal: Dis Markers Date: 2015-04-02 Impact factor: 3.434
Authors: Clizia Chinello; Marta Cazzaniga; Gabriele De Sio; Andrew James Smith; Erica Gianazza; Angelica Grasso; Francesco Rocco; Stefano Signorini; Marco Grasso; Silvano Bosari; Italo Zoppis; Mohammed Dakna; Yuri E M van der Burgt; Giancarlo Mauri; Fulvio Magni Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240